Repair of large cranial defects by hBMP-2 expressing bone marrow stromal cells: Comparison between alginate and collagen type I systems

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 2, 2010, Pages 433-441

  Chang, Sophia Chia Ning ^a,b   Chung, Hui Ying ^a   Tai, Ching Lung ^c   Chen, Philips Kuo Ting ^d   Lin, Tsung Min ^a   Jeng, Long Bin ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Alginate; BMP 2; Bone marrow stromal cells; Collagen type I

Indexed keywords

ALGINATE; BIOMECHANICS; COLLAGEN; DEFECTS; GENE TRANSFER; HYDROGELS; REPAIR; SCAFFOLDS; STEM CELLS;

ALGINATE SCAFFOLDS; BIOMECHANICAL TESTING; BIOMECHANICAL TESTS; BONE MARROW STROMAL CELLS; BONE REGENERATION; BONE REPAIR; BONE STRENGTH; COLLAGEN TYPE I; CRANIAL BONE; EX-VIVO; GROSS EXAMINATIONS; NEGATIVE IMPACTS; TYPE I COLLAGEN;

BONE;

ALGINIC ACID; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; TISSUE SCAFFOLD; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; GLUCURONIC ACID; HEXURONIC ACID;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; BIOMECHANICS; BMP 2 GENE; BONE MARROW CELL; BONE REGENERATION; BONE REMODELING; CANCELLOUS BONE; CELL TRANSPLANTATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; GENE; GENE TRANSFER; HYDROGEL; MINIPIG; NONHUMAN; PROTEIN EXPRESSION; SKULL DEFECT; STROMA CELL; TISSUE ENGINEERING; ADENOVIRIDAE; ANIMAL; CELL CULTURE; CHEMISTRY; COMPRESSIVE STRENGTH; CYTOLOGY; EVALUATION STUDY; GENE VECTOR; GENETICS; HUMAN; IMPLANT; MATERIALS TESTING; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SKULL; SURGERY; SWINE; WOUND HEALING;

ADENOVIRIDAE; ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CELL TRANSPLANTATION; CELLS, CULTURED; COLLAGEN TYPE I; COMPRESSIVE STRENGTH; GENETIC VECTORS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; IMPLANTS, EXPERIMENTAL; MATERIALS TESTING; SKULL; STROMAL CELLS; SWINE; TISSUE ENGINEERING; WOUND HEALING;

EID: 77953841773     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32685     Document Type: Article

References (59)

1. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926.
2. Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 1997;79:1778-1790.
3. Rabie AB, Chay SH, Wong AM. Healing of autogenous intramembranous bone in the presence and absence of homologous demineralized intramembranous bone. Am J Orthod Dentofacial Orthop 2000;117:288-297.
4. Niederwanger M, Urist MR. Demineralized bone matrix supplied by bone banks for a carrier of recombinant human bone morphogenetic protein (rhBMP-2): A substitute for autogeneic bone grafts. J Oral Implantol 1996;22:210-215.
5. Furukawa T, Matsusue Y, Yasunaga T, Nakagawa Y, Okada Y, Shikinami Y, Okuno M, Nakamura T. Histomorphometric study on high-strength hydroxyapatite/poly(L-lactide) composite rods for internal fixation of bone fractures. J Biomed Mater Res 2000;50:410-419. (Pubitemid 30180734)
6. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999;20:45-53.
7. Wang L, Shelton RM, Cooper PR, Lawson M, Triffitt JT, Barralet JE. Evaluation of sodium alginate for bone marrow cell tissue engineering. Biomaterials 2003;24:3475-3481.
8. Paige KT, Cima LG, Yaremchuk MJ, Schloo BL, Vacanti JP, Vacanti CA. De novo cartilage generation using calcium alginate-chondrocyte constructs. Plast Reconstr Surg 1996;97:168-178.
9. Paige KT, Cima LG, Yaremchuk MJ, Vacanti JP, Vacanti CA. Injectable cartilage. Plast Reconstr Surg 1995;96:1390-1398.
10. Oest ME, Dupont KM, Kong HJ, Mooney DJ, Guldberg RE. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res 2007;25:941-950.
11. Cai X, Lin Y, Ou G, Luo E, Man Y, Yuan Q, Gong P. Ectopic osteogenesis and chondrogenesis of bone marrow stromal stem cells in alginate system. Cell Biol Int 2007;31:776-783. (Pubitemid 46765134)
12. d'Ayala GG, De RA, Laurienzo P, Malinconico M. Development of a new calcium sulphate-based composite using alginate and chemically modified chitosan for bone regeneration. J Biomed Mater Res A 2007;81:811-820.
13. Wang Z, Goh J, Das DS, Ge Z, Ouyang H, Chong JS, Low SL, Lee EH. Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng 2006;12:1753-1761.
14. Weinand C, Gupta R, Huang AY, Weinberg E, Madisch I, Qudsi RA, Neville CM, Pomerantseva I, Vacanti JP. Comparison of hydrogels in the in vivo formation of tissue-engineered bone using mesenchymal stem cells and beta-tricalcium phosphate. Tissue Eng 2007;13:757-765.
15. Chang SCN, Rowley JA, Tobias G, Genes NG, Roy AK, Mooney DJ, Vacanti CA, Bonassar LJ. Injection molding of chondrocyte/alginate constructs in the shape of facial implants. J Biomed Mater Res 2001;55:503-511.
16. Dard M, Sewing A, Meyer J, Verrier S, Roessler S, Scharnweber D. Tools for tissue engineering of mineralized oral structures. Clin Oral Investig 2000;4:126-129.
17. Quinn TM, Grodzinsky AJ. Longitudinal modulus and hydraulic permeability of poly(methacrylic acid) gels: effects of charge density and solvent content. Macromolecules 1993;26:4332-4338.
18. Evangelista MB, Hsiong SX, Fernandes R, Sampaio P, Kong HJ, Barrias CC, Salema R, Barbosa MA, Mooney DJ, Granja PL. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials 2007;28:3644-3655.
19. van den DJ, Jansen JA. The response of osteoblast-like cells towards collagen type I coating immobilized by p-nitrophenylchloroformate to titanium. J Biomed Mater Res A 2007;83:712-719.
20. Rammelt S, Schulze E, Witt M, Petsch E, Biewener A, Pompe W, Zwipp H. Collagen type I increases bone remodelling around hydroxyapatite implants in the rat tibia. Cells Tissues Organs 2004;178:146-157.
21. Wiles MV, Keller G. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 1991;111:259-267. (Pubitemid 21920413)
22. Metcalf D. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 1989;339:27-30.
23. Goshima J, Goldberg VM, Caplan AI. The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin Orthop Relat Res 1991;269:274-283.
24. Gitelman SE, Kobrin MS, Ye JQ, Lopez AR, Lee A, Derynck R. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J Cell Biol 1994;126:1595-1609. (Pubitemid 24284621)
25. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994;127(6 Part 1):1755-1766.
26. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 1991;113:681-687.
27. Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 1993;12:871-880.
28. Rosen V, Nove J, Song JJ, Thies RS, Cox K, Wozney JM. Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res 1994;9:1759-1768.
29. Gerhart TN, Kirker-Head CA, Kriz MJ, Holtrop ME, Hennig GE, Hipp J, Schelling SH, Wang E. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop Relat Res 1993;293:317-326.
30. Lou J, Xu F, Merkel K, Manske P. Gene therapy: Adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 1999;17:43-50.
31. Pound JC, Green DW, Roach HI, Mann S, Oreffo RO. An ex vivo model for chondrogenesis and osteogenesis. Biomaterials 2007;28:2839-2849.
32. Lou J, Manske PR, Aoki M, Joyce ME. Adenovirus-mediated gene transfer into tendon and tendon sheath. J Orthop Res 1996;14:513-517. (Pubitemid 26278086)
33. Heise C, Sampson-Johannes A, Williams A, McCormick F, Von Hoff DD, Kirn DH. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat Med 1997;3:639-645.
34. Lansdown AB, Payne MJ. An evaluation of the local reaction and biodegradation of calcium sodium alginate (Kaltostat) following subcutaneous implantation in the rat. J R Coll Surg Edinb 1994;39:284-288.
35. Shapiro L, Cohen S. Novel alginate sponges for cell culture and transplantation. Biomaterials 1997;18:583-590.
36. Kume T, Takehisa M. Effect of gamma-irradiation on sodium alginate and carrageenan powder. Agric Biol Chem 1983;47:889-890. (Pubitemid 13061845)
37. Nagasawa N, Mitomo H, Yoshii F, Kume T. Radiation-induced degradation of sodium alginate. Polym Degrad Stab 2000;69:279-285.
38. Haug A, Larsen B, Smidsrod O. A study of constitution of alginic acid by partial acid hydrolysis. Acta Chem Scand 1966;20:183-190.
39. Bouhadir KH, Kruger GM, Lee KY, Mooney DJ. Sustained and controlled release of daunomycin from cross-linked poly(aldehyde guluronate) hydrogels. J Pharm Sci 2000;89:910-919.
40. Tsujino I, Saito T. A new unsaturated uronide isolated from alginase hydrolysate. Nature 1961;192:970-971.
41. Nakada HI, Sweeny PC. Alginic acid degradation by eliminases from abalone hepatopancreas. J Biol Chem 1967;242:845-851.
42. Shimokawa T, Yoshida S, Takeuchi T, Murata K, Ishii T, Kusakabe I. Preparation of two series of oligo-guluronic acids from sodium alginate by acid hydrolysis and enzymatic degradation. Biosci Biotechnol Biochem 1996;60:1532-1534.
43. Bouhadir KH, Lee KY, Alsberg E, Damm KL, Anderson KW, Mooney DJ. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog 2001;17:945-950.
44. Kong HJ, Lee KY, Mooney DJ. Decoupling the dependence of rheological/mechanical properties of hydrogels from solids concentration. Polymer 2002;43:6239-6246.
45. Alshamkhani A, Duncan R. Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in-vivo. J Bioactive Compatible Polym 1995;10:4-13.
46. Alsberg E, Anderson KW, Albeiruti A, Franceschi RT, Mooney DJ. Cell-interactive alginate hydrogels for bone tissue engineering. J Dent Res 2001;80:2025-2029.
47. Alsberg E, Anderson KW, Albeiruti A, Rowley JA, Mooney DJ. Engineering growing tissues. Proc Natl Acad Sci USA 2002;99:12025-12030.
48. Alsberg E, Kong HJ, Hirano Y, Smith MK, Albeiruti A, Mooney DJ. Regulating bone formation via controlled scaffold degradation. J Dent Res 2003;82:903-908.
49. Lawson MA, Barralet JE, Wang L, Shelton RM, Triffitt JT Adhesion and growth of bone marrow stromal cells on modified alginate hydrogels. Tissue Eng 2004;10:1480-1491. (Pubitemid 39557851)
50. Yamaoka H, Asato H, Ogasawara T, Nishizawa S, Takahashi T, Nakatsuka T, Koshima I, Nakamura K, Kawaguchi H, Chung UI, et al. Cartilage tissue engineering using human auricular chondrocytes embedded in different hydrogel materials. J Biomed Mater Res A 2006;78:1-11.
51. Connelly JT, Garcia AJ, Levenston ME. Inhibition of in vitro chondrogenesis in RGD-modified three-dimensional alginate gels. Biomaterials 2007;28:1071-1083.
52. Simmons CA, Alsberg E, Hsiong S, Kim WJ, Mooney DJ. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004;35:562-569.
53. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 1992;74:659-670.
54. Preece A. A Manual for Histologic Technicians. Boston: Little Brown and Company; 1972. p 57-73.
55. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 1991;117:1101-1112.
56. Muschler GF, Hyodo A, Manning T, Kambic H, Easley K. Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin Orthop Relat Res 1994;308:229-240. (Pubitemid 24349333)
57. Cook SD, Dalton JE, Tan EH, Tejeiro WV, Young MJ, Whitecloud TS III. In vivo evaluation of anterior cervical fusions with hydroxylapatite graft material. Spine 1994;19:1856-1866.
58. Hopper RA, Zhang JR, Fourasier VL, Morova-Protzner I, Protzner KF, Pang CY, Forrest CR. Effect of isolation of periosteum and dura on the healing of rabbit calvarial inlay bone grafts. Plast Reconstr Surg 2001;107:454-462.
59. Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 1996;17:175-185.